🔎 Trials Near Me

Hjem › Blødning › Californien

Blødning kliniske forsøg i Californien

12 studier for Blødning søger deltagere på steder i Californien.

Byer i Californien

Officiel studietekst (engelsk)

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • The Regents of the University of California||UC Davis Health, Rancho Cordova
  • UC Davis Health, Sacramento
  • UC Davis Ambulatory Care Clinic, Sacramento
  • og 3 flere
RekruttererFase 3
Alder 18 og opefter · Mænd · Opdateret 2. okt. 2026 · NCT05568719

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

  • Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco, San Francisco
RekruttererFase 2
Alder 18 til 90 · Alle køn · Opdateret 29. sep. 2026 · NCT05958342

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  • Mission Cardiovascular Research Institute, Fremont
  • National Institute of California Heart and Vein Specialists, Huntington Beach
  • Profound Research LLC at San Diego Cardiovascular Associates, La Jolla
  • og 5 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07626411

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  • Valley Clinical Trials, Inc, Covina
  • North Coast Cardiology, Encinitas
  • Mission Cardiovascular Research Institute, Fremont
  • og 7 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07175428

Onyx™ Liquid Embolic IDE Clinical Study

  • University of California, Irvine, Irvine
  • Stanford Medical Center, Palo Alto
Rekrutterer
Alder 22 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT06742801

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06948318

Oxytocin Pharmacokinetics and Pharmacodynamics

  • Stanford University, Stanford
RekruttererFase 2
Alder 18 til 50 · Kvinder · Opdateret 21. aug. 2026 · NCT05488457

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Lucile Packard Children's Hospital, Palo Alto
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 0 til 20 · Alle køn · Opdateret 21. aug. 2026 · NCT04278404

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

  • Torrance Memorial, Torrance
RekruttererFase 3
1 Month · Alle køn · Opdateret 30. jun. 2026 · NCT06664775

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  • University of Southern California, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • Stanford University, Stanford
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 26. jun. 2026 · NCT04045665

Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes

  • University of California San Diego, San Diego
  • Planned Parenthood of the Pacific Southwest, San Diego
RekruttererFase 4Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Kvinder · Opdateret 15. jun. 2026 · NCT06820177

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.